CBD News

A White House committee is recommending changes to business categories that would re-classify cannabis retail stores alongside smoking shops, among other updates.

Lately, CBD brands have started adding adaptogens—plants and mushrooms with healing properties—into their products. Unfortunately, they rarely attribute these ancient medicines to their historical and cultural context.

Cannabis dispensaries in Massachusetts are now allowed to sell most consumer-ready hemp products including hemp seeds, oils, powders, proteins, clothing and other items made from hemp fiber, hemp building materials, and non-food CBD products.

A Senate bill is seeking to finally regulate the production and sales of hemp-derived CBD products including infused foods, beverages, and dietary supplements.

The Better Business Bureau issued warnings about a CBD free trial scam that has cost customers hundreds of dollars.

UK-based GW Pharmaceuticals — the manufacturer of Epidiolex, the first FDA-approved cannabis medication — was awarded the Queen’s Award for Enterprise 2021 in the Innovation category.

Phillip Morris, the maker of Marlboro cigarettes, is reportedly considering a smoke-free entrance to the cannabis space.

Canopy Growth has agreed to a distribution deal with alcohol distributor Southern Glazer’s Wine & Spirits for its line of CBD-infused beverages.

New York City-based Angel CBD has filed suit against FedEx and New York City over a 2019 hemp shipment that was wrongfully seized by the NYPD.

The ‘Your CBD Store’ shops in Iowa have finally reopened following the 2019 arrest of owner Lacie Navin for hemp-related drug charges.

France is launching a two-year medical cannabis experiment involving 3,000 registered patients.

A recent study found that a two-week course of high doses of CBD can restore the function of two different proteins that are key in reducing the effects of Alzheimer’s disease.

Federal regulators have issued their final orders against CBD brands targeted in last year’s “Operation CBDeceit” crackdown.

CBD Industries LLC — which was formally registered as cbdMD and still trades under that name — is suing Majik Medicine for infringement. Notably, Majik Medicine holds a trademark from 2017 for the “CBD MD” moniker, which cbdMD argues was erroneously awarded.

The Chief Marketing Officer for British American Tobacco, the world’s second-largest tobacco company, said CBD is “an exciting growth area” for the company’s future.

A recently published German study showed that cannabis could be a promising treatment for reducing pain and muscle cramps in Parkinson’s patients.

GW Pharmaceuticals, creator of the first FDA-approved medication made from cannabis, is set to be purchased by Jazz Pharmaceuticals in a $7.2 billion cash-and-stock deal.